KDA GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 CAD | -1.23% |
|
-4.76% | +100.00% |
| Sales 2022 | 28.82M 21.08M 1.76B | Sales 2023 | 161K 118K 9.83M | Capitalization | 13.6M 9.95M 829M |
|---|---|---|---|---|---|
| Net income 2022 | -4M -2.93M -244M | Net income 2023 | 16M 11.7M 976M | EV / Sales 2022 | 1.26 x |
| Net Debt 2022 | 19.93M 14.58M 1.22B | Net cash position 2023 | 1.34M 983K 81.96M | EV / Sales 2023 | 76 x |
| P/E ratio 2022 |
-3.57
x | P/E ratio 2023 |
0.79
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 74.45% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.23% | ||
| 1 week | -4.76% | ||
| Current month | -5.88% | ||
| 3 months | +60.00% | ||
| 6 months | +263.64% | ||
| Current year | +100.00% |
1 week
0.38
0.45
1 month
0.380.50
Current year
0.140.66
1 year
0.030.66
3 years
0.030.66
5 years
0.030.66
10 years
0.030.75
| Managers | Title | Age | Since |
|---|---|---|---|
Marc Lemieux
CEO | Chief Executive Officer | - | 01/15/01 |
Michael Kinley
DFI | Director of Finance/CFO | 73 | 01/15/01 |
Yves Marmet
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Marc Lemieux
CEO | Chief Executive Officer | - | 01/15/01 |
Patrick Fernet
BRD | Director/Board Member | - | 01/15/01 |
Michael Kinley
DFI | Director of Finance/CFO | 73 | 01/15/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 0.4 | -1.23% | 274,200 |
| 25/24/25 | 0.405 | -3.57% | 64,160 |
| 24/24/24 | 0.42 | +9.09% | 20,800 |
| 23/24/23 | 0.385 | -7.23% | 60,005 |
| 22/24/22 | 0.415 | -1.19% | 186,099 |
Delayed Quote Toronto S.E., April 27, 2024 at 01:29 am IST
More quotes
KDA Group Inc. is a Canada-based solution and services provider to pharmacies and pharmaceutical companies in Canada as well as technological platform for the health industry. The Companyâs segments include Pharmacy Services, Pharmaceutical Solutions and Pharmaceutical Technology. Its Pharmacy Services segment offers training, consulting, and replacement services for professional resources in the field of healthcare. Its Pharmaceutical Solutions segment is engaged in the development and integration of technological platforms dedicated to all healthcare professionals. Its Pharmaceutical technology segment offers KRX, KRX DENTAL and ADRX platforms. It also offers ZRx Digital Prescriber an electronic prescriber computer and mobile software designed and developed for use by healthcare providers who are authorized to prescribe medications and other treatments. Its subsidiaries include Alliance Pharma Operations Inc., Elitis Pharma Inc., Logistik Pharma Inc. and Groupe Technologique KDA Inc.
Calendar
16/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +100.00% | 51.25M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- KDA Stock
